213 related articles for article (PubMed ID: 20079732)
1. Breast cancer cell surface annexin II induces cell migration and neoangiogenesis via tPA dependent plasmin generation.
Sharma M; Ownbey RT; Sharma MC
Exp Mol Pathol; 2010 Apr; 88(2):278-86. PubMed ID: 20079732
[TBL] [Abstract][Full Text] [Related]
2. Angiogenesis-associated protein annexin II in breast cancer: selective expression in invasive breast cancer and contribution to tumor invasion and progression.
Sharma MR; Koltowski L; Ownbey RT; Tuszynski GP; Sharma MC
Exp Mol Pathol; 2006 Oct; 81(2):146-56. PubMed ID: 16643892
[TBL] [Abstract][Full Text] [Related]
3. Antibody-directed neutralization of annexin II (ANX II) inhibits neoangiogenesis and human breast tumor growth in a xenograft model.
Sharma M; Blackman MR; Sharma MC
Exp Mol Pathol; 2012 Feb; 92(1):175-84. PubMed ID: 22044461
[TBL] [Abstract][Full Text] [Related]
4. Silencing of the annexin II gene down-regulates the levels of S100A10, c-Myc, and plasmin and inhibits breast cancer cell proliferation and invasion.
Zhang J; Guo B; Zhang Y; Cao J; Chen T
Saudi Med J; 2010 Apr; 31(4):374-81. PubMed ID: 20383413
[TBL] [Abstract][Full Text] [Related]
5. Antibody-directed targeting of angiostatin's receptor annexin II inhibits Lewis Lung Carcinoma tumor growth via blocking of plasminogen activation: possible biochemical mechanism of angiostatin's action.
Sharma MR; Rothman V; Tuszynski GP; Sharma MC
Exp Mol Pathol; 2006 Oct; 81(2):136-45. PubMed ID: 16643891
[TBL] [Abstract][Full Text] [Related]
6. The role of plasminogen-plasmin system in cancer.
Kwaan HC; McMahon B
Cancer Treat Res; 2009; 148():43-66. PubMed ID: 19377918
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen activator inhibitor type 2 inhibits cell surface associated tissue plasminogen activator in vitro: potential receptor interactions.
Lobov S; Croucher DR; Saunders DN; Ranson M
Thromb Haemost; 2008 Aug; 100(2):319-29. PubMed ID: 18690354
[TBL] [Abstract][Full Text] [Related]
8. Matrilysin (matrix metalloprotease-7) cleaves membrane-bound annexin II and enhances binding of tissue-type plasminogen activator to cancer cell surfaces.
Tsunezumi J; Yamamoto K; Higashi S; Miyazaki K
FEBS J; 2008 Oct; 275(19):4810-23. PubMed ID: 18721140
[TBL] [Abstract][Full Text] [Related]
9. The role of annexin II in angiogenesis and tumor progression: a potential therapeutic target.
Sharma MC; Sharma M
Curr Pharm Des; 2007; 13(35):3568-75. PubMed ID: 18220793
[TBL] [Abstract][Full Text] [Related]
10. The topology of plasminogen binding and activation on the surface of human breast cancer cells.
Andronicos NM; Ranson M
Br J Cancer; 2001 Sep; 85(6):909-16. PubMed ID: 11556845
[TBL] [Abstract][Full Text] [Related]
11. Herpesviruses enhance fibrin clot lysis.
Gershom ES; Vanden Hoek AL; Meixner SC; Sutherland MR; Pryzdial EL
Thromb Haemost; 2012 Apr; 107(4):760-8. PubMed ID: 22318336
[TBL] [Abstract][Full Text] [Related]
12. Thrombin induces endothelial cell-surface exposure of the plasminogen receptor annexin 2.
Peterson EA; Sutherland MR; Nesheim ME; Pryzdial EL
J Cell Sci; 2003 Jun; 116(Pt 12):2399-408. PubMed ID: 12724354
[TBL] [Abstract][Full Text] [Related]
13. Annexin II expression is reduced or lost in prostate cancer cells and its re-expression inhibits prostate cancer cell migration.
Liu JW; Shen JJ; Tanzillo-Swarts A; Bhatia B; Maldonado CM; Person MD; Lau SS; Tang DG
Oncogene; 2003 Mar; 22(10):1475-85. PubMed ID: 12629510
[TBL] [Abstract][Full Text] [Related]
14. Tissue plasminogen activator increases canine endothelial cell proliferation rate through a plasmin-independent, receptor-mediated mechanism.
Welling TH; Huber TS; Messina LM; Stanley JC
J Surg Res; 1996 Nov; 66(1):36-42. PubMed ID: 8954829
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer.
Xu X; Wang B; Ye C; Yao C; Lin Y; Huang X; Zhang Y; Wang S
Cancer Lett; 2008 Mar; 261(2):147-57. PubMed ID: 18171602
[TBL] [Abstract][Full Text] [Related]
16. S100A10, annexin A2, and annexin a2 heterotetramer as candidate plasminogen receptors.
Kwon M; MacLeod TJ; Zhang Y; Waisman DM
Front Biosci; 2005 Jan; 10():300-25. PubMed ID: 15574370
[TBL] [Abstract][Full Text] [Related]
17. Plasminogen binding and activation at the breast cancer cell surface: the integral role of urokinase activity.
Stillfried GE; Saunders DN; Ranson M
Breast Cancer Res; 2007; 9(1):R14. PubMed ID: 17257442
[TBL] [Abstract][Full Text] [Related]
18. Annexin A2 regulates the levels of plasmin, S100A10 and Fascin in L5178Y cells.
Hou Y; Yang L; Mou M; Hou Y; Zhang A; Pan N; Qiang R; Wei L; Zhang N
Cancer Invest; 2008 Oct; 26(8):809-15. PubMed ID: 18608216
[TBL] [Abstract][Full Text] [Related]
19. Tissue plasminogen activator induces pancreatic cancer cell proliferation by a non-catalytic mechanism that requires extracellular signal-regulated kinase 1/2 activation through epidermal growth factor receptor and annexin A2.
Ortiz-Zapater E; Peiró S; Roda O; Corominas JM; Aguilar S; Ampurdanés C; Real FX; Navarro P
Am J Pathol; 2007 May; 170(5):1573-84. PubMed ID: 17456763
[TBL] [Abstract][Full Text] [Related]
20. The p11 subunit of the annexin II tetramer plays a key role in the stimulation of t-PA-dependent plasminogen activation.
Kassam G; Le BH; Choi KS; Kang HM; Fitzpatrick SL; Louie P; Waisman DM
Biochemistry; 1998 Dec; 37(48):16958-66. PubMed ID: 9836589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
